Moderna's
COVID Vaccine is an 'operating system' - Is this Transhumanism?
Documents obtained from
Moderna reveal that the so-called vaccine
being peddled by the company is actually an 'operating system'.
This startling admission
confirms what vaccine skeptics have claimed - that
COVID is about
control, not a 'virus'...
It won't be lost on anyone who has done due diligence over this
pandemic to see past the glib claims of paid-off politicians and
compliant media that all is not as it seems.
To start, it is no coincidence that one of the key promoters of
these new mRNA 'vaccines' is none other than Microsoft billionaire,
Bill Gates.
vaccines can
help cut global population by 15 percent...
Yes he said cut population...
How does that work
- by deactivating these vaccine-implanted operating systems in us?
Well,
psychopathic
Bill couldn't fix his Microsoft operating system to prevent endless
computer viruses, so why should we trust him now that he is
spearheading what is seen as a major step towards
transhumanism.
For those who care
about what goes into their bodies, and those of their loved ones,
see if you can detect something very sinister from what is being
foisted upon a gullible public.
Over at The
Corbett Report readers can enlighten themselves as to the
very real dangers of transhumanism - the idea of a 'fantastic
future' in which humans merge fully with machines.
Transhumanists take
science as their religion and believe in a philosophy of "absolute
relativism" that claims that individuals can change reality at will,
and they seek to "relativize the human being."
Certainly, everyone
who holds strong religious beliefs, in whatever faith, will baulk at
what is far from a benign doctrine.
Transhumanism
is at complete enmity with Christianity, Judaism, Islam,
etc.
Over at
tapnewswire.com contributor Weaver posts the following
which is alleged to be from Moderna's documents on the new
COVID-19
vaccines.
We
built Moderna on the guiding premise that if using
mRNA as a medicine works for one disease, it should
work for many diseases.
And, if this is possible - given the right approach
and infrastructure - it could meaningfully
improve how medicines are discovered, developed and
manufactured.
Our
Operating System
Recognizing the broad potential of mRNA science, we
set out to create an mRNA technology platform that
functions very much like an operating system on a
computer...
It is designed so that it can plug and
play interchangeably with different programs.
In
our case, the "program" or "app" is our mRNA drug -
the unique mRNA sequence that codes for a protein.
We
have a dedicated team of several hundred scientists
and engineers solely focused on advancing Moderna's
platform technology.
They are organized around key disciplines and work
in an integrated fashion to advance knowledge
surrounding mRNA science and solve for challenges
that are unique to mRNA drug development.
Some of these disciplines include mRNA biology,
chemistry, formulation & delivery, bioinformatics
and protein engineering.
Our mRNA
Medicines - The 'Software of Life'
When we have a
concept for a new mRNA medicine and begin research, fundamental
components are already in place.
Generally, the
only thing that changes from one potential mRNA medicine to
another is the coding region - the actual genetic code that
instructs
ribosomes to make protein.
Utilizing these
instruction sets gives our investigational mRNA medicines a
software-like quality.
We also have
the ability to combine different mRNA sequences encoding for
different proteins in a single mRNA investigational medicine.
We are
leveraging the flexibility afforded by our platform and the
fundamental role mRNA plays in protein synthesis to pursue mRNA
medicines for a broad spectrum of diseases.
Within a given modality, the base components
are generally identical across development
candidates - formulation, 5' region and 3'
region.
Only the coding region varies based on the
protein/s the potential medicine is
directing cells to produce.
Learn how our Research
Engine and Early
Development Engine are enabling us to fully
maximize the promise of mRNA to meaningfully
improve how medicines are discovered, developed and
manufactured.
Overcoming Key Challenges
Using mRNA to create medicines is a complex
undertaking and requires overcoming novel scientific
and technical challenges.
We
need to get the mRNA into the targeted tissue and
cells while evading the immune system. If the immune
system is triggered, the resultant response may
limit protein production and, thus, limit the
therapeutic benefit of mRNA medicines.
We
also need ribosomes to think the mRNA was produced
naturally, so they can accurately read the
instructions to produce the right protein.
And
we need to ensure the cells express enough of the
protein to have the desired therapeutic effect.
Our
multidisciplinary platform teams work together
closely to address these scientific and technical
challenges.
This intensive cross-functional collaboration has
enabled us to advance key aspects of our platform
and make significant strides to deliver mRNA
medicines for patients.
